SE0003092D0 - New Use - Google Patents

New Use

Info

Publication number
SE0003092D0
SE0003092D0 SE0003092A SE0003092A SE0003092D0 SE 0003092 D0 SE0003092 D0 SE 0003092D0 SE 0003092 A SE0003092 A SE 0003092A SE 0003092 A SE0003092 A SE 0003092A SE 0003092 D0 SE0003092 D0 SE 0003092D0
Authority
SE
Sweden
Prior art keywords
new use
optionally
peri
pollen
women
Prior art date
Application number
SE0003092A
Other languages
English (en)
Inventor
Kaj Winter
Christer Hedman
Lars Kaernerud
Original Assignee
Natumin Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natumin Pharma Ab filed Critical Natumin Pharma Ab
Priority to SE0003092A priority Critical patent/SE0003092D0/sv
Publication of SE0003092D0 publication Critical patent/SE0003092D0/sv
Priority to JP2002522914A priority patent/JP2004507507A/ja
Priority to AT01963652T priority patent/ATE283061T1/de
Priority to EP01961556A priority patent/EP1313494B1/en
Priority to CA2420823A priority patent/CA2420823C/en
Priority to AT01961554T priority patent/ATE283058T1/de
Priority to JP2002522915A priority patent/JP2004507508A/ja
Priority to CA002424146A priority patent/CA2424146A1/en
Priority to DE60107444T priority patent/DE60107444T2/de
Priority to AU8458101A priority patent/AU8458101A/xx
Priority to CA002424026A priority patent/CA2424026A1/en
Priority to JP2002522917A priority patent/JP4896354B2/ja
Priority to AU2001284581A priority patent/AU2001284581B2/en
Priority to AT01961556T priority patent/ATE286739T1/de
Priority to EP01961554A priority patent/EP1313492B1/en
Priority to DE60107442T priority patent/DE60107442D1/de
Priority to AU8281401A priority patent/AU8281401A/xx
Priority to AT01961555T priority patent/ATE283059T1/de
Priority to AU2001282813A priority patent/AU2001282813A1/en
Priority to AU2001282815A priority patent/AU2001282815A1/en
Priority to DE60107441T priority patent/DE60107441D1/de
Priority to PCT/SE2001/001849 priority patent/WO2002017942A1/en
Priority to AU2001282814A priority patent/AU2001282814B2/en
Priority to EP01961555A priority patent/EP1313493B1/en
Priority to AU2001282816A priority patent/AU2001282816A1/en
Priority to JP2002522916A priority patent/JP2004507509A/ja
Priority to CA2420906A priority patent/CA2420906C/en
Priority to PL360652A priority patent/PL202468B1/pl
Priority to DE60108402T priority patent/DE60108402D1/de
Priority to EP01961557A priority patent/EP1313495B1/en
Priority to PCT/SE2001/001850 priority patent/WO2002017943A1/en
Priority to PCT/SE2001/001851 priority patent/WO2002017944A1/en
Priority to AT01961557T priority patent/ATE283060T1/de
Priority to PCT/SE2001/001847 priority patent/WO2002017940A1/en
Priority to JP2002522913A priority patent/JP2004507506A/ja
Priority to EP01963652A priority patent/EP1313496B1/en
Priority to CA002424011A priority patent/CA2424011A1/en
Priority to DE60107443T priority patent/DE60107443D1/de
Priority to PCT/SE2001/001848 priority patent/WO2002017941A1/en
Priority to NO20030988A priority patent/NO330691B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Husbandry (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
SE0003092A 2000-09-01 2000-09-01 New Use SE0003092D0 (sv)

Priority Applications (40)

Application Number Priority Date Filing Date Title
SE0003092A SE0003092D0 (sv) 2000-09-01 2000-09-01 New Use
AU2001282815A AU2001282815A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain
AU2001282813A AU2001282813A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of dysphoria
DE60107441T DE60107441D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
EP01961556A EP1313494B1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain
CA2420823A CA2420823C (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of irritability
AT01961554T ATE283058T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
JP2002522915A JP2004507508A (ja) 2000-09-01 2001-08-31 被刺激性の処置のための、花粉抽出物を含む組成物の使用
CA002424146A CA2424146A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
DE60107444T DE60107444T2 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen
AU8458101A AU8458101A (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of edema
CA002424026A CA2424026A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of dysphoria
JP2002522917A JP4896354B2 (ja) 2000-09-01 2001-08-31 ホルモン関連疾病の処置のための、花粉抽出物を含む組成物
AU2001284581A AU2001284581B2 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of edema
AT01961556T ATE286739T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
PCT/SE2001/001849 WO2002017942A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of irritability
DE60107442T DE60107442D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit
AU8281401A AU8281401A (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of irritability
AT01961555T ATE283059T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit
JP2002522914A JP2004507507A (ja) 2000-09-01 2001-08-31 浮腫の処置のための、花粉抽出物を含む組成物の使用
PCT/SE2001/001848 WO2002017941A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of edema
JP2002522913A JP2004507506A (ja) 2000-09-01 2001-08-31 情動不安の処置のための、花粉抽出物を含む組成物の使用
EP01961554A EP1313492B1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of dysphoria
AU2001282814A AU2001282814B2 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of irritability
EP01961555A EP1313493B1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of irritability
AU2001282816A AU2001282816A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
JP2002522916A JP2004507509A (ja) 2000-09-01 2001-08-31 疾患関連体重増加の処置のための、花粉抽出物を含む組成物の使用
CA2420906A CA2420906C (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of edema
PL360652A PL202468B1 (pl) 2000-09-01 2001-08-31 Zastosowanie kompozycji zawierającej ekstrakt z pyłku i ewentualnie słupków do wytwarzania leku
DE60108402T DE60108402D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
EP01961557A EP1313495B1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
PCT/SE2001/001850 WO2002017943A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain
PCT/SE2001/001851 WO2002017944A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
AT01961557T ATE283060T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen
PCT/SE2001/001847 WO2002017940A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of dysphoria
AT01963652T ATE283061T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen
EP01963652A EP1313496B1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of edema
CA002424011A CA2424011A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain
DE60107443T DE60107443D1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen
NO20030988A NO330691B1 (no) 2000-09-01 2003-03-03 Anvendelse av en sammensetning omfattende et pollenekstrakt for behandling av hormonrelaterte forstyrrelser i forbindelse med menopause hos kvinner samt sammensetning omfattende slikt ekstrakt.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0003092A SE0003092D0 (sv) 2000-09-01 2000-09-01 New Use

Publications (1)

Publication Number Publication Date
SE0003092D0 true SE0003092D0 (sv) 2000-09-01

Family

ID=20280860

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0003092A SE0003092D0 (sv) 2000-09-01 2000-09-01 New Use

Country Status (10)

Country Link
EP (5) EP1313496B1 (sv)
JP (5) JP4896354B2 (sv)
AT (5) ATE283061T1 (sv)
AU (7) AU8281401A (sv)
CA (5) CA2424026A1 (sv)
DE (5) DE60107444T2 (sv)
NO (1) NO330691B1 (sv)
PL (1) PL202468B1 (sv)
SE (1) SE0003092D0 (sv)
WO (5) WO2002017940A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005139150A (ja) * 2003-11-10 2005-06-02 Api Co Ltd エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び飲食品
US7887851B2 (en) * 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
CN104027100A (zh) * 2014-06-12 2014-09-10 山东中弘信息科技有限公司 一种基于最近历史值的血压异常数据处理方法
KR101533197B1 (ko) * 2014-09-18 2015-07-02 성균관대학교산학협력단 부테인을 포함하는 부종의 예방 또는 치료용 조성물
FR3055215B1 (fr) * 2016-08-31 2020-02-14 S.A.M. Serelys Pharma Composition comprenant des extraits de pollen et /ou de pistils
CN106138856A (zh) * 2016-09-30 2016-11-23 四川易创生物科技有限公司 一种治疗经间期出血的新型中药组合物及制备方法
EP3335717A1 (en) * 2016-12-13 2018-06-20 Serelys Pharma S.A.M. Composition for use in treating symptoms relating to premenstrual syndrome (pms)
FR3070263B1 (fr) 2017-08-28 2020-07-24 Serelys Pharma S A M Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2970957B2 (ja) * 1991-05-15 1999-11-02 株式会社グレイトチレン 精製花粉栄養調整物
ES2081255B1 (es) * 1994-01-05 1996-09-01 Ind Farma Especial Aplicacion de las proteinas receptoras de autoincompatibilidad (slsg) de plantas para el tratamiento de las enfermedades alergicas.
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH09278665A (ja) * 1996-04-10 1997-10-28 Api Kk 花粉エキスソフトカプセル剤及びその製造方法
AU2548899A (en) * 1998-02-23 1999-09-06 Taiyo Kagaku Co. Ltd. Composition comprising theanine

Also Published As

Publication number Publication date
DE60107443D1 (de) 2004-12-30
DE60108402D1 (de) 2005-02-17
JP2004507507A (ja) 2004-03-11
AU8281401A (en) 2002-03-13
JP2004507508A (ja) 2004-03-11
ATE283058T1 (de) 2004-12-15
EP1313493A1 (en) 2003-05-28
EP1313496A1 (en) 2003-05-28
WO2002017940A1 (en) 2002-03-07
JP2004507509A (ja) 2004-03-11
DE60107444T2 (de) 2005-12-08
WO2002017943A1 (en) 2002-03-07
AU2001282813A1 (en) 2002-03-13
CA2420906C (en) 2014-07-15
WO2002017942A1 (en) 2002-03-07
WO2002017941A1 (en) 2002-03-07
CA2424026A1 (en) 2002-03-07
NO20030988D0 (no) 2003-03-03
ATE283060T1 (de) 2004-12-15
AU2001282815A1 (en) 2002-03-13
AU2001282814B2 (en) 2006-12-21
DE60107442D1 (de) 2004-12-30
CA2424146A1 (en) 2002-03-07
EP1313493B1 (en) 2004-11-24
CA2420906A1 (en) 2002-03-07
JP2004507510A (ja) 2004-03-11
EP1313492A1 (en) 2003-05-28
CA2420823C (en) 2014-07-15
PL360652A1 (en) 2004-09-20
AU2001284581B2 (en) 2006-09-21
PL202468B1 (pl) 2009-06-30
JP4896354B2 (ja) 2012-03-14
AU2001282816A1 (en) 2002-03-13
NO330691B1 (no) 2011-06-14
NO20030988L (no) 2003-03-03
EP1313494A1 (en) 2003-05-28
ATE283061T1 (de) 2004-12-15
EP1313495A1 (en) 2003-05-28
JP2004507506A (ja) 2004-03-11
ATE283059T1 (de) 2004-12-15
EP1313495B1 (en) 2004-11-24
CA2420823A1 (en) 2002-03-07
DE60107444D1 (de) 2004-12-30
ATE286739T1 (de) 2005-01-15
EP1313494B1 (en) 2005-01-12
AU8458101A (en) 2002-03-13
EP1313496B1 (en) 2004-11-24
DE60107441D1 (de) 2004-12-30
WO2002017944A1 (en) 2002-03-07
CA2424011A1 (en) 2002-03-07
EP1313492B1 (en) 2004-11-24

Similar Documents

Publication Publication Date Title
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
AR023715A1 (es) Composicion farmaceutica para un sujeto que necesita una elevacion del contenido de nad intracelular, y el uso de la misma para la manufactura de unmedicamento para aumentar las respuestas celulares protectoras al stress genotoxico en la piel
WO1997048391A3 (en) Methods and compositions comprising r-ibuprofen
EA200201000A1 (ru) Гормон-заместительная терапия
DK1071439T3 (da) Hybenformuleringer som antiinflammatorisk naturmedicin til lindring/reduktion af symptomer associeret med inflammation og artritis
ATE332136T1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
EA200301022A1 (ru) Гормональная заместительная терапия
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
TR200103710T2 (tr) Vajinal mukozayı etkileyen patolojilerin topikal tedavisinde kullanıma yönelik E vitamini
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
SE0003092D0 (sv) New Use
HUP0401427A2 (hu) A hajas fejbőr kezelésére szolgáló orális készítmény
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
ATE284996T1 (de) Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
WO2002024216A3 (en) Method for use of igf-binding protein for selective sensitization of target cells in vivo
BR0314787A (pt) Forma de dosagem de liberação modificada
WO2001043705A3 (en) Compositions containing a retinoid and a stilbene for skin care
SE0000303D0 (sv) Novel compounds
AR023464A1 (es) Usos novedosos de la proteina ox2 de mamifero y reactivos relacionados
MD1473F2 (en) Antiherpetic remedy
Chandrashekar Comparative study on the efficacy of Topical Curcumin as a gel and as Buccal Mucoadhesive Patch in the management of oral Submucous Fibrosis-A clinicobiochemical evaluation
ZA200207846B (en) Topical antioxidant vitamin composition for skin care.
WO2002036747A3 (en) Peripheral nerve type sodium channels
Peters et al. Striæ Atrophicæ.? Dyspituitarism